Overview

Buphenyl Therapy for Byler's Disease

Status:
No longer available

Trial end date:
1969-12-31

Target enrollment:

Participant gender:

Summary

This is a single patient compassionate use protocol to determine whether Buphenyl (4-phenylbutyrate) will improve the poor bile flow associated with Byler Disease.

Details

Lead Sponsor:

University of Pittsburgh

Treatments:

4-phenylbutyric acid